Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)

CUSIP: 53630X203

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
5,578,947
Total 13F shares
477,372
Share change
+476,607
Total reported value
$2,400,563
Price per share
$5.03
Number of holders
22
Value change
+$2,397,563
Number of buys
21

Quarterly Holders Quick Answers

What is CUSIP 53630X203?
CUSIP 53630X203 identifies LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) as of Q2 2023

As of 30 Jun 2023, Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 477,372 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, WEALTH EFFECTS LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Kestra Advisory Services, LLC, TWO SIGMA INVESTMENTS, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.